Business Segments · Antitrust legal settlements
North American Pharmaceutical — Antitrust legal settlements
McKesson North American Pharmaceutical — Antitrust legal settlements remained flat by 0.0% to $5.75M in Q4 2026 compared to the prior quarter. Year-over-year, this metric declined by 61.7%, from $15M to $5.75M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ3 2024
Last reportedQ4 2026May 8, 2026
Rolls up toProceeds from legal settlements
How to read this metric
An increase represents higher legal risk and potential negative impact on segment margins, while a decrease suggests a reduction in litigation-related liabilities.
Detailed definition
This metric tracks the financial impact of legal settlements specifically related to antitrust litigation within the Nor...
Peer comparison
Commonly reported by major pharmaceutical wholesalers who face systemic industry litigation, comparable to peers in the 'Big Three' wholesalers.
Metric ID:
mck_segment_north_american_pharmaceutical_antitrust_legal_settlementsHistorical Data
8 periods
| Q3 '24 | Q4 '24 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $63M | $31M | $0 | $15M | $5.75M | $5.75M | $5.75M | $5.75M |
| QoQ Change | — | -50.8% | -100.0% | — | -61.7% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | -100.0% | -51.6% | — | — | — | -61.7% |
Range$0 – $63M
CAGR-74.5%
Avg YoY Growth-71.1%
Median YoY Growth-61.7%
Current Streak3 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's north american pharmaceutical — antitrust legal settlements?
- McKesson (MCK) reported north american pharmaceutical — antitrust legal settlements of $5.75M in Q4 2026.
- How has McKesson's north american pharmaceutical — antitrust legal settlements changed year-over-year?
- McKesson's north american pharmaceutical — antitrust legal settlements decreased by 61.7% year-over-year, from $15M to $5.75M.
- What does north american pharmaceutical — antitrust legal settlements mean?
- Financial costs incurred from legal settlements related to antitrust issues within the North American Pharmaceutical segment.